Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1α) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis
2011

PGC-1α Improves Motor Performance and Survival in ALS Mice

Sample size: 8 publication Evidence: moderate

Author Information

Author(s): Zhao Wei, Varghese Merina, Yemul Shrishailam, Pan Yong, Cheng Alice, Marano Paul, Hassan Sadiq, Vempati Prashant, Chen Fei, Qian Xianjuan, Pasinetti Giulio M

Primary Institution: Mount Sinai School of Medicine

Hypothesis

Does PGC-1α play a protective role in ALS?

Conclusion

PGC-1α may be a potential therapeutic target for ALS therapy.

Supporting Evidence

  • PGC-1α significantly improves motor function in SOD1-G93A mice.
  • SOD1-G93A/PGC-1α mice had a median survival of 139 days, longer than the 129 days of SOD1-G93A mice.
  • Motor neuron counts were higher in SOD1-G93A/PGC-1α mice compared to SOD1-G93A mice.

Takeaway

Researchers found that a protein called PGC-1α helps mice with ALS move better and live longer.

Methodology

The study used a double transgenic mouse model to assess the effects of PGC-1α on motor performance and survival.

Participant Demographics

Mice used were SOD1-G93A transgenic and PGC-1α transgenic.

Statistical Information

P-Value

0.0078

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1750-1326-6-51

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication